Table 3 describes the number and the nature of adverse event that led to the discontinuation of iron replacement therapy. Five out of 203 patients who received IV iron discontinued because of infusion related reactions,2 small bowel hemorrhage,1 thrombophlebitis1 and thrombocytopenia.